KUGLÍK, Petr, Vladimíra VRANOVÁ, Pavel CEJPEK, Eva NEESALOVÁ, Martina PEŠÁKOVÁ and Jiina RELICHOVÁ. Genomic imbalance detected in glioblastoma multigorme using high-resolution comparative genomic hybridization. In Chromosome Research. UK: Springer, 2005, p. 87.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Genomic imbalance detected in glioblastoma multigorme using high-resolution comparative genomic hybridization
Name in Czech Abnormality chromozomů detegované u multiformního glioblastomu pomocí techniky komparativní genomové hybridizace s vysokým rozlišením
Authors KUGLÍK, Petr (203 Czech Republic, guarantor), Vladimíra VRANOVÁ (703 Slovakia), Pavel CEJPEK (203 Czech Republic), Eva NEESALOVÁ (203 Czech Republic), Martina PEŠÁKOVÁ (203 Czech Republic) and Jiina RELICHOVÁ (203 Czech Republic).
Edition UK, Chromosome Research, p. 87-87, 2005.
Publisher Springer
Other information
Original language English
Type of outcome Proceedings paper
Field of Study Genetics and molecular biology
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14310/05:00014596
Organization unit Faculty of Science
Keywords in English Glioblastoma multiforme; chromosome aberrations; HR-CGH; FISH
Tags chromosome aberrations, FISH, glioblastoma multiforme, HR-CGH
Changed by Changed by: doc. RNDr. Petr Kuglík, CSc., učo 1881. Changed: 15/1/2007 11:07.
Abstract
Glioblastoma multiforme (GBM) is the most common form of primary neoplasm occurring in the central nervous system of adults. The tumour can develop from a low-degree or anaplastic astrocyte secondary glioblastoma, but more frequently it manifests itself with a short clinical anamnesi as primary glioblastoma. Cytogenetic diagnostic methods form an integral part glioblastoma diagnostics, however, conventional cytogenetics has been unable to identify consistent chromosomal aberrations in this group of tumours. Thus, more advanced molecular cytogenetic approaches are required to study the relationship between chromosomal instability and patient prognosis. The aim of this study was to screen for chromosomal imbalances in GBM by CGH and modified HR-CGH. Aim was to determine chromosomal changes on primary tumours and evaluate intratumoral genetic heterogenity by comparing gains and losses of chromosomes in central and peripheral areas of tumours. In this study, chromosomal abnormalities in 22 cases of GBM were analysed using CGH. A total of 99 different changes were observed (with a median of 5 changes per case). The most prominent gains were found in chromosomes 7, 19, 3q, 12, Xp. The losses concerned mainly chromosome 10, 6, 13q, 14q, 1p. Losses of chromosomal material (56) were more frequent than gains (43). To further increase detection rate of chromosomal imbalances, we applied HR-CGH in 11 cases GBM. HR-CGH revealed more aberrations per patiens than did CGH. A total of 172 abnormalities were found with HR-CGH (with a median of 9 changes per case). Low frequent aberrant clones with whole chromosome gains as well as losses of chromosomal segments were further revealed by HR-CGH. Furthermore, our data confirmed genetic heterogenity of GBM; gains and losses of DNA sequences have been found to a much lesser extend in central areas compared to the peripheral areas of tumours.
Abstract (in Czech)
Práce se zabývá výskytem specifických chromozomových abnormalit u mozkového nádoru multiformního glioblastomu, které byly studovány pomocí techniky komparativní genomové hybridizace s vysokým rozlišením.
Links
MSM0021622415, plan (intention)Name: Molekulární podstata buněčných a tkáňových regulací
Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations
OC B19.001, research and development projectName: Genová diagnostika a terapie multiformního glioblastomu (Acronym: COST)
Investor: Ministry of Education, Youth and Sports of the CR, Gene Diagnostics and Therapy of Multiform Glioblastoma
PrintDisplayed: 26/4/2024 15:03